María Pellecchia, L., & Manuel Correa, F. J. (2025). Comparison of clinical efficacy and dosing regimens between Nirsevimab and Palivizumab for prophylaxis against RSV in the pediatric population. SAP Primary Care, 1, 18. https://doi.org/10.62486/pc202518